Lung oncology Clinical Trials in Milwaukee, WI
As of July 2026, 19 paid clinical trials are recruiting for Lung oncology in Milwaukee, Wisconsin. Lung oncology trials investigate EGFR, ALK, KRAS, and other driver-mutation targeted therapies alongside immunotherapy combinations for non-small cell, small cell, and mesothelioma studies. Compensation typically covers time, travel, and study visits, and many studies also include study-related medical care at no cost.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Filter results
19 clinical trials for Lung oncology
·Clear filters·↓ Download CSVA Study of Ifinatamab Deruxtecan Versus Treatment of Physician's Choice in Subjects With Relapsed Small Cell Lung Cancer
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
A Study of Navlimetostat (BMS-986504) in Participants With Pre-treated Advanced or Metastatic Non-small Cell Lung Cancer (NSCLC) With Homozygous MTAP Deletion (MountainTAP-9)
A Study of LY4050784 in Participants With Advanced or Metastatic Solid Tumors
Safety, PK and Efficacy of QXL138AM in Patients With Solid Tumors and Multiple Myeloma
A Study to Evaluate the Safety and Efficacy of Gocatamig (MK-6070) and Ifinatamab Deruxtecan (I-DXd) in Participants With Relapsed/Refractory Extensive-Stage Small Cell Lung Cancer (MK-6070-002)
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
Testing Longer Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With Cancer That Has Spread to the Brain
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has Increased Copies of the MET Gene (An Expanded Lung-MAP Treatment Trial)
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
Dosing Physical Activity Among Older Cancer Survivors Who Experience Chronic Pain: a Micro-randomized Trial
Prospective Non-Interventional Study Comparing Osimertinib +/- Chemotherapy for EGFR-Mutated NSCLC Patients
The MOMENTUM Study: The Multiple Outcome Evaluation of Radiation Therapy Using the MR-Linac Study
Radiation Prior to TKI to Delay Progression in Advanced Driver-Mutated Non-small Cell Lung Cancers (RadiaNCe Lung X)
A Study of NT-175 in Adult Participants With Advanced Malignancies That Are Positive for HLA-A*02:01 and the TP53 R175H Mutation
Phase 1 Study to Investigate TCRTs KRAS Mutation in Unresectable, Advanced, and/or Metastatic Solid Tumors
Study of Zanzalintinib in Combination With Immuno-Oncology Agents in Participants With Solid Tumors
Phase III, Open-label Study of First-line Osimertinib With or Without Datopotamab Deruxtecan for EGFRm Locally Advanced or Metastatic Non-small Cell Lung Cancer
About research studies in Milwaukee
Milwaukee has approximately 668 recruiting research studies across a wide range of therapeutic areas. Wisconsin hosts a diverse network of universities, academic medical centers, and community hospitals that run clinical trials across oncology, cardiology, neurology, and many other therapeutic areas.
Top Research Study Locations in Milwaukee
Researchers run research studies in Milwaukee, WI at 25 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| Medical College of Wisconsin | Acute Myeloid Leukemia, Stroke, Chronic Lymphocytic Leukemia | 245 |
| Aurora Sinai Medical Center | Anatomic Stage II Breast Cancer AJCC v8, Stage IV Lung Cancer AJCC v8, Advanced Lung Non-Small Cell Carcinoma | 50 |
| Aurora Saint Luke's Medical Center | Anatomic Stage II Breast Cancer AJCC v8, Stage IV Lung Cancer AJCC v8, Advanced Lung Non-Small Cell Carcinoma | 48 |
| Aurora Cancer Care-Milwaukee | Anatomic Stage II Breast Cancer AJCC v8, Stage IV Lung Cancer AJCC v8, Advanced Lung Non-Small Cell Carcinoma | 46 |
| Children's Hospital of Wisconsin | B Acute Lymphoblastic Leukemia, Hodgkin Lymphoma, Malignant Solid Neoplasm | 44 |
| Froedtert & the Medical College of Wisconsin | Pancreatic Cancer, Refractory Multiple Myeloma, Relapse Multiple Myeloma | 21 |
| Children's Wisconsin | Abdominal Pain, Acute Lymphoblastic Leukemia in Remission, Acute Myeloid Leukemia Refractory | 21 |
| Froedtert Hospital & the Medical College of Wisconsin | Breast Cancer, Pancreas Cancer, Acute Myeloid Leukemia (AML) | 18 |
| Froedtert Hospital and the Medical College of Wisconsin | B-cell Lymphoma, Breast Cancer, Cancer | 17 |
| Aurora St. Luke's Medical Center | Pulmonary Hypertension, Acute Decompensated Heart Failure, Acute Ischemic Stroke From Large Vessel Occlusion | 15 |
| Froedtert Hospital | Aortic Stenosis, Bladder Cancer, Breast Cancer | 15 |
| The Medical College of Wisconsin | Abdominal Wound Dehiscence, Acute Kidney Injury, Anal Fistula | 12 |
| Froedtert & Medical College of Wisconsin | Cystic Fibrosis (CF), Acute Myeloid Leukemia, Acute Myeloid Leukemia (AML) | 10 |
| Marquette University | Stroke, Aging, Aerobic Exercise | 9 |
| Ascension Columbia Saint Mary's Hospital-Milwaukee Campus | Ampulla of Vater Carcinoma, Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8 | 8 |
| Froedtert and The Medical College of Wisconsin | Adenocarcinoma, Advanced Renal Cell Carcinoma (aRCC), Aggressive Variant Prostate Carcinoma | 8 |
| Ascension Columbia Saint Mary's Hospital - Milwaukee | Breast Carcinoma, Malignant Solid Neoplasm, Advanced Colorectal Carcinoma | 7 |
| Zablocki Veterans Administration Medical Center | Stage IVA Prostate Cancer AJCC v8, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia | 7 |
| Ascension Saint Francis Hospital | Malignant Solid Neoplasm, Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8 | 5 |
| Ascension Southeast Wisconsin Hospital - Saint Joseph Campus | Malignant Solid Neoplasm, Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8 | 5 |
| Aurora St Luke's Medical Center | AMI, Cancer, Cutaneous Melanoma, Stage II | 4 |
| Clement J. Zablocki VA Medical Center, Milwaukee, WI | Atherosclerosis, De Novo Prostate Cancer, Lung Neoplasm | 4 |
| Medical College of Wisconsin/Children's Hospital of Wisconsin | Primary Immune Deficiency Disorder, Adenovirus, Covid19 | 4 |
| Advocate Aurora Research Institute | Cardiovascular Diseases, Functional Mitral Regurgitation, Heart Diseases | 3 |
| Ascension Southeast Wisconsin Hospital-Saint Joseph-Milwaukee | Ampulla of Vater Carcinoma, Appendix Carcinoma, Carcinoma of Unknown Primary With Gastrointestinal Profile | 3 |
Active & Upcoming Studies in Milwaukee (2026)
Recruiting trials in Milwaukee grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Cancer & tumors (269 active studies)
- Nemtabrutinib With Venetoclax and Obinutuzumab in Patients With Chronic Lymphocytic Leukemia · Phase 2 · Medical College of Wisconsin
- Fully Human Bispecific Anti-CD20, Anti-CD19 CAR T Cells for Patients With Relapsed and/or Refractory B Cell Malignancies · Phase 1 · Medical College of Wisconsin
Cardiovascular (49 active studies)
- PAtient Similarity for Decision-Making in Prevention of Cardiovascular Toxicity (PACT): A Feasibility Study · Medical College of Wisconsin
- Peripheral Venous Pressure (PVP) Trial · Wake Forest University Health Sciences
Neurology & pain (37 active studies)
- Morphine or Ketamine for Analgesia · Phase 3 · Columbia University
- COMparison Between Anakinra and Tocilizumab in NORSE - "COMBAT-NORSE" · Phase 3 · Yale University
Diabetes & metabolic (20 active studies)
- PAtient Similarity for Decision-Making in Prevention of Cardiovascular Toxicity (PACT): A Feasibility Study · Medical College of Wisconsin
- Puerto Rican Obesity Intervention for Men · Medical College of Wisconsin
Pediatric (12 active studies)
- Amnioinfusion for Chorioamnionitis: Targeting Neonatal Brain Injury Biomarkers · Medical College of Wisconsin
- Amnioinfusion's Protective Effects on Respiratory and Longitudinal Pediatric Outcomes After Intrapartum Thick Meconium Exposure · Medical College of Wisconsin
Mental health & behavior (5 active studies)
- My Path to Quit Tobacco · Phase 4 · University of Wisconsin, Madison
- Wound Healing Following Extraction and Ridge Preservation in Smokers and Non-smokers · Marquette University
HIV / STI (4 active studies)
- Screen Smart: Using Digital Health to Improve HIV Screening and Prevention · Children's Hospital Medical Center, Cincinnati
- A Study to Evaluate the Effectiveness of Long-acting (LA) Cabotegravir (CAB) + Rilpivirine (RPV) LA When Given to Participants With Detectable HIV-1 · Phase 3 · ViiV Healthcare
Vaccines (2 active studies)
Eye & vision (1 active study)
- Phase 2 Tolerability and Effects of ALK-001 on Stargardt Disease · Phase 2 · Alkeus Pharmaceuticals, Inc.
Common conditions studied in Milwaukee
- Heart Failure (15 active studies). Heart failure trials explore SGLT-2 inhibitors, novel myosin modulators, and device-based therapies for both reduced and preserved ejection fraction.
- Acute Myeloid Leukemia (14 active studies). Leukemia trials evaluate targeted inhibitors, CAR-T cell therapies, and novel combinations for acute and chronic forms of the disease.
- Breast Cancer (13 active studies). Breast cancer trials evaluate new hormone therapies, targeted drugs, and immunotherapy combinations aimed at improving survival and reducing recurrence.
- Follicular Lymphoma (10 active studies). Lymphoma research explores bispecific antibodies, CAR-T cell therapies, and new targeted agents for Hodgkin and non-Hodgkin lymphomas.
- Prostate Cancer (10 active studies). Prostate cancer studies test next-generation hormone therapies, PARP inhibitors, and radioligand treatments for both localized and advanced disease.
- Stroke (10 active studies). Stroke trials test acute reperfusion strategies, neuroprotective agents, and rehabilitation technologies to improve recovery.
Leading research sponsors in Milwaukee
- Medical College of Wisconsin
- National Cancer Institute (NCI)
- Alliance for Clinical Trials in Oncology
- AstraZeneca
- NRG Oncology
Local regulations and guidelines
Clinical trials in Wisconsin are governed by U.S. Food and Drug Administration (FDA) regulations, Office for Human Research Protections (OHRP) standards, and federal HIPAA privacy rules. Every study is reviewed by an Institutional Review Board (IRB) to protect participant safety and ensure informed consent. Wisconsin research additionally follows state public health department oversight and any applicable state privacy statutes.
Compensation & what to expect
- How payment typically works
- Compensation is most often provided through reloadable electronic study cards or direct deposit, paid out per completed visit rather than as a lump sum. Amounts vary by the time required, the number of visits, and the study's complexity — overnight stays and inpatient pharmacology studies generally pay more than short outpatient surveys. The exact amount is disclosed in writing during informed consent before any visit.
- Healthy volunteers
- Healthy participants aged 18 and older can earn compensation by joining vaccine, pharmacology, and biomarker studies in Milwaukee. These trials check how a new drug or vaccine behaves in healthy bodies before later-phase testing. Many sites maintain a healthy-volunteer registry so you hear about new opportunities first.
- What's included beyond payment
- Most trials cover study-related medical care at no cost — physical exams, lab work, imaging, the investigational treatment itself, and follow-up visits with the research team. Insurance is not required to participate. Free check-ups and access to specialists are common reasons participants return for additional studies.
- Travel and time
- Many sponsors reimburse travel, parking, mileage, and lost wages for visit days. Long-running studies and trials that require frequent visits often raise stipends accordingly. Ask the study coordinator for the visit schedule and reimbursement policy before you commit.
- Asking about compensation
- Compensation is set per protocol and per site, so figures are not published in trial registries. The fastest way to confirm payment for a specific study is to contact the recruiting site listed on the study record. Coordinators are accustomed to this question and will quote the per-visit and total amounts up front.
How to find a clinical trial in Milwaukee
Hipa.ai aggregates every recruiting study in Milwaukee from ClinicalTrials.gov and refreshes the list daily. Use the filters above to narrow by condition, facility, age, phase, or healthy-volunteer eligibility, then click any study title to view full details — eligibility criteria, intervention, location, and sponsor contact information. To enroll, reach out to the central study contact listed on the study detail page; the research coordinator will walk you through the screening process.
Frequently asked questions
How many paid clinical trials are currently recruiting in Milwaukee?
There are approximately 668 recruiting clinical trials in Milwaukee, Wisconsin listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Milwaukee pay participants?
Most recruiting trials in Milwaukee compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Milwaukee?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Milwaukee?
The most common conditions under active study in Milwaukee include Heart Failure (15), Acute Myeloid Leukemia (14), Breast Cancer (13), Follicular Lymphoma (10), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Milwaukee?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Milwaukee on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Milwaukee?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Milwaukee?
Recruiting research sites in Milwaukee include Medical College of Wisconsin, Aurora Sinai Medical Center, Aurora Saint Luke's Medical Center, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Milwaukee right now?
The largest active categories in Milwaukee are Cancer & tumors (269), Cardiovascular (49), Neurology & pain (37). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.